Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Clinical findings at screening for patients who did and did not develop IFRS after transplantation
All at Pre-HCT Screen No Post-HCT IFRS Post-HCT IFRS P Value
No. 100 98 2 
ENT risk estimate (No.) (frequency) 
 At risk 29 (29%) 28 (29%) 1 (50%) .61
 Low risk 67 (67%) 62 (63%) 1 (50%) 
 Not evaluated 4 (4%) 8 (8%) 0 
ANC at imaging (mean) 2510 ± 5568 2524 ± 5622 1800 ± 1697 .86
Transplant donor (No.) (frequency) 
 Allogenic 66 (66%) 65 (66%) 1 (50%) 1
 Autologous 34 (34%) 33 (34%) 1 (50%) 
Disease status at transplantation (No.) (frequency) 
 Complete remission 82 (82%) 80 (80%) 2 (100%) 1
 Active disease 18 (18%) 18 (18%) 
T-cell depletion (No.) (frequency) 2 (2%) 2 (2%) 0 1
GVHD II–IV (No.) (frequency) 15 (15%) 15 (15%) 0 1
Note:—ANC indicates absolute neutrophil count.

	All at Pre-HCT Screen	No Post-HCT IFRS	Post-HCT IFRS	P Value
No.	100	98	2
ENT risk estimate (No.) (frequency)
At risk	29 (29%)	28 (29%)	1 (50%)	.61
Low risk	67 (67%)	62 (63%)	1 (50%)
Not evaluated	4 (4%)	8 (8%)	0
ANC at imaging (mean)	2510 ± 5568	2524 ± 5622	1800 ± 1697	.86
Transplant donor (No.) (frequency)
Allogenic	66 (66%)	65 (66%)	1 (50%)	1
Autologous	34 (34%)	33 (34%)	1 (50%)
Disease status at transplantation (No.) (frequency)
Complete remission	82 (82%)	80 (80%)	2 (100%)	1
Active disease	18 (18%)	18 (18%)
T-cell depletion (No.) (frequency)	2 (2%)	2 (2%)	0	1
GVHD II–IV (No.) (frequency)	15 (15%)	15 (15%)	0	1